| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
7e-05 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
7e-05 |
| mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-05 |
| mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.19 |
8e-05 |
| mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
9e-05 |
| mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
9e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0001 |